Inovio Pharmaceuticals
(NASDAQ) INO
Inovio Pharmaceuticals Financials at a Glance
Market Cap
$107.09M
Revenue (TTM)
$0.00
Net Income (TTM)
$84.95M
EPS (TTM)
$-1.93
P/E Ratio
-0.80
Dividend
$0.00
Beta (Volatility)
1.56 (High)
Dividend
$0.00
Beta (Volatility)
1.56 (High)
Price
$1.60
Volume
1,491,099
Open
$1.54
Price
$1.60
Volume
1,491,099
Open
$1.54
Previous Close
$1.61
Daily Range
$1.50 - $1.62
52-Week Range
$1.30 - $2.98
Dividend
$0.00
Beta (Volatility)
1.56 (High)
Price
$1.60
Volume
1,491,099
Open
$1.54
Previous Close
$1.61
Daily Range
$1.50 - $1.62
52-Week Range
$1.30 - $2.98
INO News
INO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Inovio Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
112
CEO
Jacqueline E. Shea, PhD
Website
www.inovio.comHeadquarters
Plymouth Meeting, PA 19462, US
INO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-183%
Return on Capital
-0%
Return on Assets
-0%
Earnings Yield
-1.25%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$107.09M
Shares Outstanding
69.09M
Volume
1.49M
Short Interest
0.00%
Avg. Volume
1.20M
Financials (TTM)
Gross Profit
$2.92M
Operating Income
$86.82M
EBITDA
$83.83M
Operating Cash Flow
$88.63B
Capital Expenditure
$285.70K
Free Cash Flow
$88.63B
Cash & ST Invst.
$58.51M
Total Debt
$9.37B
Inovio Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$65.34K
-155.9%
Gross Profit
$676.33K
+202.7%
Gross Margin
-10.35%
N/A
Market Cap
$107.09M
N/A
Market Cap/Employee
$799.20K
N/A
Employees
134
N/A
Net Income
$3.76M
+119.4%
EBITDA
$16.72M
+10.1%
Quarterly Fundamentals
Net Cash
$9.31B
-11418.5%
Accounts Receivable
$450.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$6.55B
+69838.8%
Short Term Debt
$2.82B
+112924.2%
Return on Assets
-0.11%
N/A
Return on Invested Capital
-0.28%
N/A
Free Cash Flow
$19.37B
-98408.4%
Operating Cash Flow
$19.37B
-98408.1%